ADORA2A and non-small cell lung carcinoma: Our NSCLC CSC-enriched spheres down-regulated A1R and A3R cAMP inhibitory receptors compared to the adherent counterpart, thus regulating Ado activity, concomitantly with the expression of A2AR and A2BR stimulatory receptors.